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Abstract
The palladium-catalyzed decarboxylative allylic alkylation of enol carbonates derived from 
lactams and ketones is described. Employing these substrates with an electronically tuned Pd 
catalyst system trisubstituted chiral centers are produced. These stereocenters have been 
previously challenging to achieve using Pd complex/chiral P–N ligand systems.
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1. Introduction
Development of straightforward and selective synthetic methods for enantioselective C-C 
bond formation is a fundamental goal in the area of synthetic organic chemistry.1 
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Asymmetric allylic alkylation of prochiral or racemic substrates is one of the most effective 
synthetic methods to construct stereochemically defined chiral centers.2 The well-
established nucleophilic substitution of activated allylic fragments is among the most useful 
and direct stereoselective methods for the functionalization of a variety of carbon-
nucleophiles.3 Over the last decade, our laboratory has reported Pd-catalyzed 
decarboxylative allylic alkylation reactions (Scheme 1). Since our initial efforts in this area, 
leading to the formation of α-quaternary ketones 2 from racemic β-ketoesters 1 in good 
yields and enantioselectivities using (S)-4-(tert-butyl)-2-(2-(diphenylphosphino)phenyl)-4,5-
dihydrooxazole [(S)-t-BuPHOX]4 as a chiral ligand,5 we have expanded the scope6 and 
demonstrated the use of these methods in a number of applications.7 We recently developed 
the asymmetric allylic alkylation, giving α-quaternary lactams 4 from racemic β-amidoesters 
3 using (S)-2-(2-(bis(4-(trifluoromethyl)phenyl)phosphino)-5-(trifluoromethyl)phenyl)-4-
(tert-butyl)-4,5-dihydrooxazole [(S)-(CF3)3-t-BuPHOX]8 as a chiral ligand.9 In the context 
of preparing trisubstituted tertiary stereocenters (i.e., Scheme 2, 3a), this methodology 
encountered problems; (1) allylic alkylation of β-amidoester 3a gave a mixture of mono-, di-
allylated and unallylated lactams, and (2) the ee value of 4a produced was low (Scheme 2a). 
This low mono-allylation selectivity is attributed to the fact that a deprotonated β-
carboxyamides can serve as a nucleophile to form α-allyl-β-carboxyamides, eventually 
leading to di-allylated products. Rare exceptions are found in recent work wherein we 
achieved the synthesis of α-secondary ketopiperazines,9b and some other groups developed 
asymmetric alkylation constructing trisubstituted chiral centers at the α-position of 
amides.10
Since enol carbonates cannot undergo the unwanted background deprotonation and allylic 
alkylation reaction, catalyst controlled decarboxylative allylic alkylation of enol carbonates 
should generally proceed with high mono-allylic alkylation selectivity. As expected, 
alkylation using enol carbonate 7a with Pd2(dba)3 and (S)-(CF3)-t-BuPHOX at 40 °C 
proceeded smoothly to give 4a in 90% yield with 99% ee (Scheme 2b). This high 
enantioselectivity and yield is probably due to easy kinetic access to an enolate allyl Pd 
complex, which was proposed by a DFT study in our previous report.11 Herein, we report 
the palladium-catalyzed decarboxylative allylic alkylation of enol carbonates derived from 
lactams and ketones constructing trisubstituted chiral centers at the α-position of various 
carbonyl groups.
2. Results and Discussion
The synthesis of enol carbonates 7a-f was difficult due to challenges associated with the 
formation of C-acylated compounds along with the desired O-acylated structures. In order to 
selectively O-acylate the corresponding enolate, we screened bases, solvents and additives 
using methods previously employed for synthesizing enol carbonates.10b Fortunately, 7a 
could be prepared from N-benzoylpiperidin-2-one by using potassium hexamethyldisilazide 
(KHMDS) with 18-crown-6 as an additive in THF (eq 1). O-acylation of 4-
benzoylmorpholin-3-one (6b) proceeded without any additive, presumably due to a 
stabilization effect of the endocyclic oxygen atom to favor the enolate form (eq 2). For 
thiomorpholine (6c), ε-caprolactam (6d), and azocan-2-one (6e), we used NaHMDS as a 
base and tetramethylethylenediamine (TMEDA) as an activator (eq 3). The 2-chloroallyl 
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group was introduced by using allyloxycarbonyl imidazole as an acylating reagent and 





With the enol carbonate substrates in hand, we performed allylic alkylation reactions of 
lactam-derived enol carbonates 7b-7f with Pd2(dba)3 (2.5 mol%) and (S)-(CF3)3-t-BuPHOX 
(6.25 mol%) in toluene at 23 °C for 24 h (Scheme 3). Reaction of carbonate 7b afforded 
morpholinone 4b in 73% yield and 94% ee. Replacement of oxygen with sulfur gave 
thiomorpholinone 4c in 82% yield but only 65% ee along with the formation of unallylated 
product 6b in 10% yield. Caprolactam 7d was also reactive with this catalytic system by 
using tris(4,4′-methoxydibenzylideneacetone)dipalladium(0) [Pd2(pmdba)3]12 as the 
palladium(0) source, furnishing lactam 4d in 83% yield and 85% ee. Chloride substitution at 
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the 2-position of the allyl group in 7d increased the enantioselectivity, furnishing 
caprolactam 4f in 91% ee. Ring size of the lactam significantly affected enantioselectivity, 
as the reaction of the 8-membered ring substrate 7e proceeded to give the amide 4e in 84% 
yield and 59% ee.
Next, we explored the scope of the allylation of ketones, forming α-tertiary 
alkyl(cyclo)alkanone derivatives. We were pleased to discover that use of enol carbonate 8a, 
derived from the corresponding tetralone, resulted in a smooth reaction and delivered 
allylated tetralone 9a in high yield and enantioselectivity (eq 5). It is noteworthy that the 
more challenging acyclic substrate 8b was reactive with this catalytic system as well, 




Asymmetric allylic alkylation of enol carbonates is an effective method to construct 
trisubstituted chiral centers, which have been difficult to introduce using previously 
developed systems in our laboratory. Herein, we report that a palladium/P–N catalyst system 
displays activity for enol carbonates derived from lactams. In addition, this system could be 
applied to the allylation of ketones in both cyclic and acyclic systems.
4. Experimental section
Materials and Methods
Unless otherwise stated, reactions were performed in flame-dried glassware under an argon 
or nitrogen atmosphere using dry, deoxygenated solvents. Solvents were dried by passage 
through an activated alumina column under argon.14 Reaction progress was monitored by 
thin-layer chromatography (TLC) which was performed using E. Merck silica gel 60 F254 
precoated glass plated (0.25 mm) and visualized by UV fluorescence quenching, or KMnO4 
staining. Silicycle SiliaFlash® P60 Academic Silica gel (particle size 40-63 nm) was used 
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for flash chromatography. 1H and 13C NMR spectra were recorded on a Varian Inova 500 
(500 MHz and 126 MHz, respectively) and are reported in terms of chemical shift relative to 
CHCl3 (δ 7.26 and d 77.16, respectively). Data for 1H NMR are reported as follows: 
chemical shift (δ ppm) (multiplicity, coupling constant (Hz), integration). Multiplicities are 
reported as follows: s = singlet, d = doublet, t = triplet, q = quartet, p = pentet, sept = septet, 
m = multiplet, and br s = broad singlet. IR spectra were obtained by use of a Perkin Elmer 
Spectrum BXII spectrometer using thin films deposited on NaCl plates and reported 
frequency of absorption (cm–1). Optical rotations were measured with a Jasco P-2000 
polarimeter operating on the sodium D-line (589 nm), using a 100 mm path-length cell and 
are reported as: [α]DT (concentration in g/100mL, solvent). Analytical SFC was performed 
with a Mettler SFC supercritical CO2 analytical chromatography system utilizing Chiralpak 
(AD-H, AS-H or IC) or Chiracel (OD-H, OJ-H or OB-H) columns (4.6 mm × 25 cm) 
obtained from Daicel Chemical Industries, Ltd. High resolution mass spectra were obtained 
from the Caltech Mass Spectral Facility using a JEOL JMS-600H High Resolution Mass 
Spectrometer in fast atom bombardment (FAB+), or a Agilent 6200 Series TOF with an 
Agilent G1978A Multimode source in electrospray ionization (ESI+), atmospheric pressure 
chemical ionization (APCI+), or mixed ionization mode (ESI/APCI).
Reagents were purchased from Sigma-Aldrich, Acros Organics, Strem or Alfa Aesar and 
used as received unless otherwise stated. Et3N and tetramethylethylenediamine (TMEDA) 
were distilled from calcium hydride prior to use. (S)-2-(2-(bis(4-
(trifluoromethyl)phenyl)phosphino)-5-(trifluoromethyl)phenyl)-4-(tert-butyl)-4,5-
dihydrooxazole [(S)-(CF3)3-t-BuPHOX]15 and tris(4,4′-
methoxydibenzylideneacetone)dipalladium(0) [Pd2(pmdba)3]16 were prepared by known 
methods.
4.1. General Procedure for Asymmetric Allylic Alkylation Reactions
In a nitrogen-filled glove box, [Pd2(dba)3] (4.6 mg, 0.005 mmol, 0.025 equiv.) and (S)-
(CF3)3-t-BuPHOX (7.4 mg, 0.0125 mmol, 0.0625 equiv.) were added to a 20 mL 
scintillation vial equipped with a magnetic stirring bar. The vial was then charged with 
toluene (4.0 mL) and stirred at 25 °C for 30 min. To the preformed catalyst solution was 
added a solution of enol carbonate (0.2 mmol, 1 equiv.) in toluene (2.1 mL). The vial was 
sealed and stirred at 23 °C for 24 h. The reaction mixture was concentrated in vacuo. Flash 
column chromatography (SiO2) afforded α-allylated carbonyl compounds.
4.1.1. 3-Allylpiperidin-2-one (4a)—Reaction performed in toluene at 40 °C. Compound 
4a was isolated by flash chromatography (SiO2, 7 to 10% EtOAc in hexanes) as a white 
solid. 90% yield. Rf = 0.31 (17% EtOAc in hexanes). M.p. 66.5-67.2 °C; 99% ee, [α]D25 
-77.1 (c 1.00, CHCl3). 1H NMR (500 MHz, CDCl3) δ 7.56-7.50 (m, 2H), 7.47 (m, 1H), 
7.42–7.35 (m, 2H), 5.77 (m, 1H), 5.13–5.05 (m, 2H), 3.89–3.74 (m, 2H), 2.67–2.54 (m, 2H), 
2.28 (m, 1H), 2.14–2.02 (m, 2H), 1.96 (m, 1H), 1.68 (m, 1H). 13C NMR (126 MHz, CDCl3) 
δ 175.8, 174.8, 136.5, 135.6, 131.5, 128.3, 127.9, 117.5, 46.2, 43.8, 35.3, 26.8, 22.1. IR 
(Neat Film, NaCl) 3073, 2947, 2870, 1699, 1679, 1641, 1478, 1367, 1288, 1167, 1153, 
1076, 1056, 1025, 1001 cm-1. HRMS (ESI+) m/z calc'd for C15H18NO2 [M+H]+: 244.1332, 
Kita et al. Page 5









found 244.1372. SFC conditions: 5% MeOH, 2.5 mL/min, Chiralpak AD-H column, λ = 254 
nm, tR (min): major = 9.10, minor = 6.18.
4.1.2. 2-Allylmorpholin-3-one (4b)—Reaction performed in toluene at 50 °C. 
Compound 4b was isolated by flash chromatography (SiO2, 7 to 10% EtOAc in hexanes) as 
a white solid. 73% yield. Rf = 0.52 (33% EtOAc in hexanes). 94% ee, [α]D25 -127.5 (c 0.80, 
CHCl3). 1H NMR (500 MHz, CDCl3) δ 7.57–7.48 (m, 3H), 7.42–7.38 (m, 2H), 5.91 (m, 
1H), 5.23–5.16 (m, 2H), 4.23 (m, 2H), 4.04 (m, 1H), 3.93–3.82 (m, 2H), 2.73 (m, 1H), 2.62 
(m, 1H). 13C NMR (126 MHz, CDCl3) δ 173.2, 171.3, 135.7, 133.4, 132.0, 128.3, 128.2, 
118.5, 78.5, 63.4, 45.3, 36.3. IR (Neat Film, NaCl) 3358, 3076, 2977, 2898, 2867, 1686, 
1642, 1601, 1583, 1463, 1449, 1432, 1398, 1374, 1301, 1282, 1228, 1178, 1165, 1138, 
1124, 1104 cm-1. HRMS (ESI+) m/z calc'd for C14H16NO3 [M+H]+: 246.1125, found 
246.1124. SFC conditions: 5% MeOH, 3.0 mL/min, Chiralpak OD-H column, λ = 254 nm, 
tR (min): major = 6.74, minor = 5.99.
4.1.3. 2-Allyl-4-benzoylthiomorpholin-3-one (4c)—Reaction performed in toluene at 
40 °C. Compound 4c was isolated by flash chromatography (SiO2, 15% EtOAc in hexanes) 
as a white solid. 82% yield. Rf = 0.51 (33% EtOAc in hexanes). 65% ee, [α]D25 -31.1 (c 
0.36, CHCl3). 1H NMR (500 MHz, CDCl3) δ 7.61–7.57 (m, 2H), 7.51 (m, 1H), 7.45–7.38 
(m, 2H), 5.85 (m, 1H), 5.20–5.10 (m, 2H), 4.78 (ddd, J = 14.2, 4.8, 3.4 Hz, 1H), 3.79 (dd, J 
= 7.7, 5.7 Hz, 1H), 3.73 (ddd, J = 14.2, 11.7, 4.2 Hz, 1H), 3.16 (m, 1H), 3.10 (td, J = 11.7, 
4.8 Hz, 1H), 2.76 (m, 1H), 2.35 (m, 1H). 13C NMR (126 MHz, CDCl3) δ 173.2, 171.6, 
135.6, 134.1, 132.0, 128.2, 128.1, 118.1, 43.6, 42.2, 33.3, 26.9. IR (Neat Film, NaCl) 3362, 
3065, 2933, 1687, 1600, 1580, 1534, 1450, 1378, 1326, 1281, 1177, 1132, 1071, 1026 cm-1. 
HRMS (FAB+) m/z calc'd for C14H16NO2S [M+H]+: 262.0902, found 262.0895. SFC 
conditions: 5% MeOH, 3.0 mL/min, Chiralcel OD-H column, λ = 254 nm, tR (min): major = 
9.26, minor = 8.79.
4.1.4. 3-Allyl-1-benzoylazepan-2-one (4d)—Reaction performed in toluene at 40 °C. 
Compound 4d was isolated by flash chromatography (SiO2, 10% EtOAc in hexanes) as a 
yellow oil. 83% yield. Rf = 0.44 (17% EtOAc in hexanes). 85% ee, [α]D25 -33.9 (c 1.90, 
CHCl3). 1H NMR (500 MHz, CDCl3) 7.55–7.49 (m, 2H), 7.46 (m, 1H), 7.40–7.34 (m, 2H), 
5.78 (m, 1H), 5.11–5.03 (m, 2H), 4.56 (dd, J = 14.8, 5.8 Hz, 1H), 3.44 (ddd, J = 14.8, 10.7, 
0.9 Hz, 1H), 2.83 (m, 1H), 2.55 (m, 1H), 2.12–1.96 (m, 3H), 1.90 (m, 1H), 1.74–1.44 (m, 
3H). 13C NMR (126 MHz, CDCl3) δ 178.7, 174.5, 136.8, 136.2, 131.4, 128.1, 127.7, 117.1, 
45.9, 44.5, 36.4, 30.2, 28.8, 28.7. IR (Neat Film, NaCl) 3073, 3030, 2931, 2857, 1681, 1641, 
1600, 1583, 1513, 1490, 1450, 1396, 1360, 1322, 1282, 1220, 1189, 1177, 1141, 1114, 
1044, 1018, 1001 cm-1. HRMS (ESI+) m/z calc'd for C16H20NO2 [M+H]+: 258.1489, found 
258.1494. SFC conditions: 5% MeOH, 3.0 mL/min, Chiralcel AD-H column, λ = 254 nm, tR 
(min): major = 4.48, minor = 4.88.
4.1.5. 3-Allyl-1-benzoylazocan-2-one (4e)—Reaction performed in toluene at 23°C. 
Compound 4e was isolated by flash chromatography (SiO2, 10% EtOAc in hexanes) as a 
yellow oil. 84% yield. Rf = 0.50 (17% EtOAc in hexanes). 59% ee, [α]D25 -8.6 (c 0.37, 
CHCl3). 1H NMR (300 MHz, CDCl3) δ 7.56–7.22 (m, 5H), 5.80 (ddt, J = 17.2, 10.5, 6.9 Hz, 
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1H), 5.18–5.02 (m, 2H), 4.19 (ddd, J = 15.1, 4.3, 3.0 Hz, 1H), 3.85 (ddd, J = 15.1, 12.6, 2.8 
Hz, 1H), 3.01 (m, 1H), 2.53 (m, 1H), 2.21–2.05 (m, 2H), 1.92–1.70 (m, 4H), 1.70–1.35 (m, 
3H). 13C NMR (126 MHz, CDCl3) δ 180.7, 174.9, 136.8, 136.1, 131.3, 128.1, 127.9, 117.4, 
45.1, 44.0, 38.0, 36.7, 31.2, 25.9, 24.5. IR (Neat Film, NaCl) 3067, 2928, 2857, 1679, 1619, 
1493, 1448, 1392, 1319, 1285, 1246, 1176, 1125, 1091 cm-1. HRMS (ESI+) m/z calc'd for 
C17H22NO2 [M+H]+: 272.1645, found 272.1656. SFC conditions: 5% MeOH, 3.0 mL/min, 
Chiralcel OJ-H column, λ = 254 nm, tR (min): major = 2.97, minor = 3.87.
4.1.6. 1-Benzoyl-3-(2-chloroallyl)azepan-2-one (4f)—Reaction performed in toluene 
at 23 °C. Compound 4f was isolated by flash chromatography (SiO2, 15% EtOAc in 
hexanes) as a yellow oil. 42% yield. Rf = 0.37 (17% EtOAc in hexanes). 91% ee, [α]D25 
-78.1 (c 1.20, CHCl3). 1H NMR (500 MHz, CDCl3) δ 7.56–7.50 (m, 2H), 7.46 (m, 1H), 
7.41–7.29 (m, 2H), 5.26 (d, J = 1.2 Hz, 1H), 5.19 (d, J = 1.2 Hz, 1H), 4.58 (dd, J = 15.1, 5.1 
Hz, 1H), 3.50 (dd, J = 15.1, 11.0 Hz, 1H), 3.23 (m, 1H), 2.85 (ddd, J = 14.6, 6.4, 1.0 Hz, 
1H), 2.32 (ddd, J = 14.6, 7.7, 0.7 Hz, 1H), 2.15–1.99 (m, 2H), 1.89 (m, 1H), 1.78–1.55 (m, 
2H), 1.48 (m, 1H). 13C NMR (126 MHz, CDCl3) δ 178.0, 174.5, 140.0, 136.7, 131.6, 128.2, 
127.9, 115.5, 44.7, 43.5, 41.6, 29.6, 28.9, 28.7. IR (Neat Film, NaCl) 2931, 2857, 1683, 
1636, 1450, 1397, 1358, 1321, 1274, 1220, 1188, 1148, 1126 cm-1. HRMS (ESI+) m/z 
calc'd for C16H19ClNO2 [M+H]+: 292.1099, found 292.1104. SFC conditions: 5% MeOH, 
3.0 mL/min, Chiralcel OD-H column, λ = 254 nm, tR (min): major = 5.89, minor = 4.97.
4.1.7. 2-Allyl-3,4-dihydronaphthalen-1(2H)-one (9a)—Reaction performed in toluene 
at 40 °C. Compound 9a was isolated by flash chromatography (SiO2, 0 to 3% EtOAc in 
hexanes) as a pale colorless oil. 91% yield. Rf = 0.40 (9% EtOAc in hexanes). 90% ee, 
[α]D25 +26.6 (c 0.61, CHCl3). 1H NMR (300 MHz, CDCl3) δ8.04 (dd, J = 7.9, 1.5 Hz, 1H), 
7.46 (td, J = 7.5, 1.5 Hz, 1H), 7.36–7.16 (m, 2H), 5.95–5.75 (m, 1H), 5.18–5.01 (m, 2H), 
3.00 (dd, J = 7.8, 4.5 Hz, 2H), 2.76 (m, 1H), 2.55 (m, 1H), 2.36–2.16 (m, 2H), 1.87 (m, 
1H). 13C NMR (126 MHz, CDCl3) δ 199.5, 144.2, 136.4, 133.3, 132.8, 128.8, 127.7, 126.8, 
116.9, 47.4, 34.2, 28.8, 28.2. IR (Neat Film, NaCl) 3073, 2976, 2929, 1686, 1682, 1640, 
1600, 1455 1435, 1359, 1293, 1280, 1220, 1156 cm-1. HRMS (ESI/APCI+) m/z calc'd for 
C13H15O [M+H]+: 187.1117, found 187.1110. SFC conditions: 0.5% MeCN, 3.0 mL/min, 
Chiralcel OD-H column, λ = 254 nm, tR (min): major = 8.11, minor = 7.74.
4.1.8. 2-Methyl-1-phenylpent-4-en-1-one (9b)—Reaction performed in toluene at 23 
°C. Compound 9b was isolated by flash chromatography (SiO2, 0 to 3% EtOAc in hexanes) 
as a colorless oil. Quant. Rf = 0.43 (10% EtOAc in hexanes). 81% ee, [α]D25 -32.9 (c 0.50, 
CH2Cl2). 1H NMR (500 MHz, CDCl3) δ 8.02–7.97 (m, 2H), 7.60 (m, 1H), 7.55–7.47 (m, 
2H), 5.83 (m, 1H), 5.14–5.02 (m, 2H), 3.60 (m, 1H), 2.61 (m, 1H), 2.25 (m, 1H), 1.26 (d, J 
= 6.9 Hz, 3H). 13C NMR (126 MHz, CDCl3) δ 203.6, 136.4, 135.8, 132.9, 128.7, 128.3, 
116.8, 40.4, 37.6, 17.0. IR (Neat Film, NaCl) 3077, 2975, 2933, 2358, 1682, 1641, 1596, 
1579, 1447, 1374, 1360, 1239, 1209 cm-1. HRMS (ESI/APCI+) m/z calc'd for C12H15O [M
+H]+: 175.1117, found 175.1113. SFC conditions: 0.5% MeCN, 3.0 mL/min, Chiralcel OD-
H column, λ = 254 nm, tR (min): major = 3.97, minor = 4.42.
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Allylic alkylation of ketones and lactams using Pd(0) complex and chiral P–N ligand system
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Comparison of β-amidoester (3a) and enol carbonate (7a).
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Substrate scope of enol carbonates. Reaction conditions: A mixture of 7 (0.20 mmol), 
Pd2(dba)3 (0.005 mmol), and (S)-(CF3)3-t-BuPHOX (0.0125 mmol) in toluene (0.033 M) 
was stirred at 23 °C for 24 h. Yield was isolated yield and enantiomeric excess was 
determined by chiral SFC analysis. aPerformed at 50 °C. bPerformed at 40 
°C. c[Pd2(pmdba)3] was used as a catalyst.
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